CRB Opens Second Office in Europe, Hires Bernd Müller

STUTTGART, Germany, Oct. 5, 2018 /PRNewswire/ -- CRB, a leading provider of design and consulting solutions for the global life science marketplace, has announced the opening of a new office in Stuttgart, Germany. The office supports the growing need for experts in project execution to support the pharmaceutical and biotechnology industry in the region.

"The opening of operations for CRB in Germany strategically aligns with our clients' growth in the region over the last decade and allows us to serve their needs locally," CRB president, Ryan Schroeder, said. "In addition, Germany'scommitment to research and manufacturing in the life science industry makes it a natural fit for the expertise of our team."

CRB has hired Bernd Müller as the project team leader in the Stuttgart office. Müller has more than 20 years of experience in the industry, managing teams on major projects for European companies, including Octapharma, CSL Behring, Roche Diagnostics, Boehringer Ingelheim and more.

"The addition of Bernd in Stuttgart to our European network is key to our continued growth in the region," Eric Unrau, CRB's regional leader for Europe, said. "Whether it's a small research study or a complex construction project, we will be able to better serve our clients by having a team that is "on the ground.""

CRB's offices in Basel, Switzerland and Stuttgart, Germany will continue to focus on life science projects in Europe.

Media Contact: 

United States
Katie Helmsing 

Patricia Zöbelin  


Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.